Cloning of Nt.CviQII Nicking Endonuclease and Its Cognate Methyltransferase: M.CviQII Methylates AG Sequence by Chan, Siu-Hong et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Papers in Plant Pathology Plant Pathology Department 
9-2006 
Cloning of Nt.CviQII Nicking Endonuclease and Its Cognate 
Methyltransferase: M.CviQII Methylates AG Sequence 
Siu-Hong Chan 
New England Biolabs, Inc., Ipswich, MA 
Zhenyu Zhu 
New England Biolabs, Inc., 240 County Road, Ipswich, MA 
David Dunigan 
University of Nebraska-Lincoln, ddunigan2@unl.edu 
James L. Van Etten 
University of Nebraska-Lincoln, jvanetten1@unl.edu 
Shuang-yong Xu 
New England Biolabs, Inc., 240 County Road, Ipswich, MA 
Follow this and additional works at: https://digitalcommons.unl.edu/plantpathpapers 
 Part of the Plant Pathology Commons 
Chan, Siu-Hong; Zhu, Zhenyu; Dunigan, David; Van Etten, James L.; and Xu, Shuang-yong, "Cloning of 
Nt.CviQII Nicking Endonuclease and Its Cognate Methyltransferase: M.CviQII Methylates AG Sequence" 
(2006). Papers in Plant Pathology. 123. 
https://digitalcommons.unl.edu/plantpathpapers/123 
This Article is brought to you for free and open access by the Plant Pathology Department at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Papers in Plant Pathology by 
an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
The chlorella viruses are large, icosahedral, plaque-
forming, genetically diverse but morphologically similar 
viruses. They have linear dsDNA genomes (315–380 kb) 
and belong to the family Phycodnaviridae, genus Chlorovi-
rus [1]. The prototype chlorella virus, Paramecium bursaria 
chlorella virus (PBCV-1) has a 331-kb genome that con-
tains ~366 protein-encoding genes of 65 or more codons 
and a polycistronic tRNA operon encoding 11 tRNAs. 
The chloroviruses infect certain fresh water, unicellular, 
eukaryotic chlorella-like green algae, which normally ex-
ist as endosymbionts in the protozoan P. bursaria.
One distinctive feature of the chlorella viruses is that 
they contain genes encoding Type II DNA site-specific 
restriction endonucleases (REases) and their companion 
DNA methyltransferases (MTases), collectively referred 
to as restriction-modification (R-M) systems. REases rec-
ognize and cleave specific nucleotide sequences, while 
their companion DNA MTases protect DNA from cleav-
age by methylating one of the nucleotides in the same 
nucleotide sequence. The number of MTase genes varies 
from virus to virus. For example PBCV-1 has five MTase-
encoding genes, two of which have companion REases, 
whereas virus NY-2A has at least 10 functional MTase-en-
coding genes [2]. As a result, the NY-2A genome is heav-
ily methylated and its genomic DNA is resistant to many 
REases [3].
Two virus-encoded site-specific DNA endonucle-
ases have been isolated from NY-2A infected chlorella 
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Abstract
Chlorella virus NY-2A has a large, highly methylated dsDNA genome (45% of the cytosines are 5-methylcytosine and 37% of 
the adenines are N6-methyladenine). Here, we report the cloning, expression, and characterization of the NY-2A-encoded CviQII 
nicking-modification (N-M) system. The nicking endonuclease, Nt.CviQII, recognizes R ↓ AG (R = A or G, ↓ indicating cleavage 
site) sequences and cleaves the phosphodiester bond 5′ to the adenosine. Because of the difficulty in cloning and expressing the 
wild-type Nt.CviQII, C-terminal truncation mutants were generated and full-length Nt.CviQII was reconstructed by intein-medi-
ated peptide ligation. The truncation mutants and the reconstructed full-length Nt.CviQII have the same recognition and cleav-
age specificity as the native enzyme. Full-length and truncated Nt.CviQII produced by a cell-free transcription/translation system 
have similar reaction rates. The methyltransferase, M.CviQII, was also cloned and expressed. It modifies the adenine in AG dou-
blets of DNA in vitro and in vivo in Escherichia coli. To our knowledge, M.CviQII is the first adenine methyltransferase that recog-
nizes a dinucleotide. Therefore, M.CviQII may be a useful reagent for blocking endonuclease cleavage when restriction sites over-
lap with AG sequences.
Keywords: Chlorella virus, intein-mediated peptide ligation, methyltransferases, nicking endonucleases, restriction-modification 
system
Abbreviations: AdoMet, S-adenosyl-methionine; BAC, bacteria artificial chromosome; CBD, chitin-binding domain; ds, double-
strand; m5C, 5-methylcytosine; m6A, 6-methyladenine; MTase, methyltransferase; NEase, nicking endonuclease; N-M, nicking-
modification system; Nt, top-strand nicking; REase, restriction endonuclease; R-M, restriction-modification; ss, single-strand; wt, 
wild-type.
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cells. R.CviQI creates double-strand breaks 5′ to the T in 
the palindromic sequence G ↓ TAC [4] and NY-2A nick-
ase makes single-strand breaks 5′ of the A in R ↓ AG se-
quences [2]. The NY-2A nickase, later named Nt.CviQII, 
is interesting because it recognizes three bases with 2-fold 
degeneracy in the first base, the shortest recognition se-
quence among all known dsDNA cleaving and nicking 
endonucleases (NEase). Its companion MTase should 
also recognize RAG or shorter sequences. Only one other 
three-base NEase has been described: Nt.CviPII encoded 
by chlorella virus NYs-1 [5, 6]. Nt.CviPII recognizes ↓CCD 
sequences (D = A, G, or T; three bases with 3-fold degen-
eracy in the third base). Therefore, cloning and charac-
terizing Nt.CviQII and its companion MTase M.CviQII 
should provide additional information on NEases that 
recognize and cleave DNA frequently. Here, we report 
expression and purification of C-terminal deletion vari-
ants of Nt.CviQII and reconstruction of the full-length en-
zyme by intein-mediated peptide ligation. Recombinant 
M.CviQII was also purified and its recognition sequence 
was found to be more degenerate than that of the cognate 
NEase.
Materials and Methods
Identification of the CviQII N-M genes
Genomic DNA from virus NY-2A was isolated from 
purified virions as described [3]. The methyltransfer-
ase selection method [7] was used to clone the cviQIIM 
gene. NY-2A genomic DNA was partially digested with 
2-fold serial dilutions of Sau3AI and ligated into BamHI-
digested and calf intestinal alkaline phosphatase (CIP)-
treated pUCAC (a derivative of pUC19 containing a 
chloramphenicol-resistant gene [6]). The ligated products 
were transformed into Escherichia coli ER1992 [Δ(argF-
lac)U169 glnV44 mcr-67 rfbD1? relA1? endA1 dinD2::
MudI1734 (KmR, lacZ+) spoT1? thi-1 Δ(mcrC-mrr)114::IS10]. 
Clones that expressed M.CviQII were selected by digest-
ing plasmid DNA from the transformed cells with MnlI 
[CCTC(N7)↓; complementary sequence ↓(N6)GAGG, ↓ 
indicating cleavage site] at 37 °C for 2 h. MnlI does not 
cleave GmAGG sequences and so MnlI-resistant plasmids 
should be expressing M.CviQII. The MnlI-treated plas-
mid library was used to transform E. coli ER2502 [fhuA2 
ara-14 leu Δ(gpt-proA)62 lacY1 glnV44 galK2 rpsL20 endA1 
R(zgb210::Tn10)TcSxyl-5 mtl-1 Δ(mcrC-mrr)HB101]. Clones 
partially resistant to MnlI were selected, which could con-
tain the cviQIIM gene. Inserts from the plasmids were se-
quenced using pUC universal forward and reverse prim-
ers as well as custom-designed primers. The sequences 
were subjected to a BLAST search against REBASE and 
GenBank [8, 9].
Genes encoding R-M systems are located adjacent to 
one another in most cases [REBASE, [8]]. Therefore, DNA 
flanking the cviQIIM gene was sequenced from the NY-2A 
genomic DNA using custom primers to look for cviQIINt.
Expression and purification of M.CviQII
The cviQIIM gene was amplified from NY-2A genomic 
DNA by PCR such that NdeI and SapI sites were added 
to the 5′ and 3′ ends of the gene, respectively. The ampli-
fied DNA was inserted into pTXB1 at NdeI and SapI sites 
so that M.CviQII was expressed as a fusion protein with a 
Mxe GyrA intein and chitin-binding domain (CBD) at its 
C-terminus [10]. E. coli ER2566 [fhuA2 lacZ::T7 gene1 [lon] 
ompT gal sulA11 [dcm] R(zgb-210::Tn10–TcS) endA1 Δ(mcrC-
mrr)114::IS10 R(mcr-73::miniTn10–TcS)2] was transformed 
by the plasmid and expression was induced with 0.25 mM 
IPTG for 3 h at 37 °C. Cells were harvested, re-suspended 
in 20 mM sodium phosphate buffer, pH 6.5, sonicated on 
ice and the disrupted cells were centrifuged at 12,000g for 
20 min at 4 °C. The fusion protein appeared as an inclu-
sion body. The pellet was washed with 0.2 M NaCl, 1% de-
oxycholate and then with 1% Triton X-100, 1 mM EDTA. 
The washed inclusion bodies were solubilized in 25 ml of 
6.5 M guanidine hydrochloride (GdnHCl), 50 mM Tris, 
0.5 M NaCl, pH 8.0, and incubated at room temperature 
for 2 h. The solubilized protein was clarified by centrifu-
gation (12,000g for 20 min at 4 °C) and added dropwise to 
a refolding buffer [55 mM MES (2-Morpholinoethanesul-
fonic acid), pH 6.5, 0.56 mM NaCl, 0.44 mM KCl, 1.1 mM 
EDTA, 1 mM DTT, 440 mM sucrose, 550 mM l-arginine, 
final pH 10.6 at 25 °C] with constant stirring at room 
temperature (FoldIt Screen protein refolding kit, Hamp-
ton Research). The solution containing the refolded pro-
tein was incubated at room temperature for 2 h and then 
with 50 mM DTT for 5 h to induce cleavage of the intein. 
The solution turned turbid after 2 h; however, SDS–PAGE 
analysis indicated that most of the cleaved M.CviQII pro-
tein remained in the soluble fraction. The soluble protein 
was dialyzed against 20 mM sodium phosphate buffer, 
0.1 M NaCl, pH 6.5 at 4 °C and cleared by centrifugation. 
Refolded protein was loaded on an SP column (15 ml bed 
volume; Amersham) and eluted using a 0.1–1.0 M NaCl 
gradient; M.CviQII eluted at ~0.3 M NaCl. Fractions con-
taining M.CviQII were pooled, concentrated, and stored 
in 50% glycerol (v/v) at −20 °C. Protein concentrations 
were determined by the Bradford method.
Cell-free transcription/translation of Nt.CviQII and its trunca-
tion mutants
Cell-free transcription/translation of Nt.CviQII was 
accomplished with the Pure System™ classic II kit (Post 
Genome Institute Co. Ltd., Tokyo, Japan). Oligonucle-
otides were designed to generate both full-length and 
truncation mutants of Nt.CviQII by PCR. Two-step PCR 
was used to incorporate a T7 promoter and ribosome-
binding sequence at the 5′ end of the genes following the 
manufacturer’s instructions. The PCR products were gel-
purified and used as templates for in vitro transcription/
translation according to the manufacturer’s instructions. 
Aliquots of the translation reactions were used directly in 
DNA nicking assays.
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Nt.CviQII truncation mutants and intein-mediated peptide 
ligation
C-terminal truncation mutants of Nt.CviQII, NQN509, 
and NQN528, which have deletions of 41 and 22 amino 
acids, respectively, were amplified from NY-2A ge-
nomic DNA by PCR. Ser509 of NQN509 and Ser528 of 
NQN528 were mutated to Cys residues to facilitate in-
tein-mediated peptide ligation. Primers were used to 
add NdeI and SapI restriction sites to the 5′ and 3′ ends 
of the PCR products, respectively. The PCR products 
were inserted into pTXB1 by the same method used to 
clone cviQIIM. After verifying the DNA sequence, the 
constructs were transformed into E. coli ER2566 for ex-
pression. Expression procedures were identical to those 
used for M.CviQII. Cells were harvested, re-suspended 
in chitin column buffer (20 mM Tris–HCl, 0.5 M NaCl, 
0.1% Triton X-100, 1 mM EDTA, pH 8.0), sonicated and 
centrifuged. Both truncated fusion proteins were solu-
ble and they were applied to a chitin column (20 ml bed 
volume). After washing the column using chitin column 
buffer, the fusion proteins were released by incubating 
the bound protein with 50 mM sodium 2-mercaptoeth-
anesulfonate (MESNA) overnight at 4 °C; the released 
proteins were eluted from the column with two-bed vol-
umes of chitin column buffer.
The truncated proteins were ligated to C-terminal pep-
tides as follows: 0.01 μmol of protein (0.7 mg) from the 
chitin column fractions was incubated with 1 μmol of pep-
tide in 1 ml of chitin column buffer with 50 mM MESNA 
at 4 °C or 25 °C overnight. The ligated proteins were pu-
rified through a heparin column (Amersham; 10 ml bed 
volume) using a NaCl gradient in 20 mM Tris–HCl, pH 
7.9. The peptides were synthesized in-house at New Eng-
land Biolabs (NEB).
The NQN509 protein was subjected to additional pu-
rification. Fractions containing NQN509 that eluted 
from the chitin column were diluted 4-fold with 20 mM 
Tris–HCl, pH 7.8 such that the NaCl concentration was 
125 mM. The diluted protein solution was applied to a 
Heparin HyperD M column (BioSepra, 30 ml bed vol-
ume), which was then eluted with a linear NaCl gradi-
ent [50 mM—1 M]. Fractions containing the truncated 
protein were pooled and dialyzed against 10 mM potas-
sium phosphate buffer, 50 mM NaCl, 1 mM EDTA, pH 
7.0, and applied to a hydroxyapatite column (Bio-Rad 
Bio-gel HTP; 15 ml bed volume). Proteins were eluted 
using a linear gradient of 10–500 mM potassium phos-
phate buffer. Peak fractions were assayed using pBR322 
DNA as a substrate, pooled, concentrated, and stored in 
20 mM Tris–HCl, 100 mM NaCl, pH 8.0, and 50% glyc-
erol at −20 °C.
In vivo and in vitro M.CviQII MTase activity
Total DNA was isolated from pUCAC-cviQIIM-trans-
formed ER2502 to measure M.CviQII MTase activity in 
vivo. One microgram of total DNA was incubated with 
10–20 U of selected REases at 37 °C for 1 h in appropri-
ate buffer conditions as suggested by the manufacturer 
(NEB). The DNA fragments were analyzed by electropho-
resis on 0.8% agarose gels.
To test in vitro activity, 1 μg of pUC19 was incubated 
with 2 μg of M.CviQII and 80 μM of S-adenosyl-methio-
nine (AdoMet) in NEB buffer 2 (10 mM Tris–HCl, 10 mM 
MgCl2, 50 mM NaCl, 1 mM DTT, pH 7.9) at 37 °C for 
1 h in 20 μl reactions. After heat-inactivation at 65 °C for 
15 min, the reaction volume was increased to 50 μl in the 
appropriate buffers (NEB) and incubated with 10–20 U of 
selected REases at 37 °C for 1 h.
DNA nicking activity assay
DNA nicking activity of the truncated and ligated 
Nt.CviQII proteins were assayed using pBR322 or pUC19 
DNA as substrates. Various amounts of protein were in-
cubated with 1 μg of DNA in NEB buffer 2 (10 mM Tris–
HCl, 10 mM MgCl2, 50 mM NaCl, 1 mM DTT, pH 7.9) at 
specific temperatures for various times. Cleaved DNA 
products were analyzed by electrophoresis on 1.5% aga-
rose gels. To determine the cleavage specificity of the 
Nt.CviQII truncation mutants, DNA cleavage fragments 
were filled-in using Klenow fragment in the presence of 
33 μmol dNTPs according to the instructions of the man-
ufacturer (NEB). These fragments were ligated into Hin-
cII- and CIP-treated pUC19. The clones were sequenced 
to identify the cleavage sites.
DNA nicking activity from full-length and truncated 
Nt.CviQII produced by cell-free transcription/translation 
was assayed as follows: one microgram of pUC19 DNA 
was incubated with 2 μl of the transcription/translation 
product in NEB buffer 2 and 1 μg of bovine serum albu-
min (BSA) in a total volume of 20 μl at 30 °C for 4 h. Four 
microliters samples were collected hourly and the re-
actions were stopped by adding 5 mM EDTA and 0.1% 
SDS. Samples were analyzed on 0.8% agarose gels and 
the intensities of the nicked DNA bands were quantified 
by Quantity One software (Bio-Rad). The results from 
two independent experiments were averaged and plotted 
against time. Curve fitting was done using KaleidaGraph 
(Synergy Software).
Identification of Nt.CviQII in NY-2A virions
Highly purified and protease K-treated PBCV-1 viri-
ons were solubilized and the virus proteins were sepa-
rated by SDS–PAGE as described previously [11]. [Note: 
Protease K at room temperature has no effect on PBCV-1 
infectivity (Van Etten, unpublished results).] The gel was 
stained with Sypro Ruby (Molecular Probes) and the re-
vealed bands were excised. The proteins in the gel slices 
were hydrolyzed by in-gel trypsin digestion [12]. The re-
sulting peptide fragments were eluted from the gel pieces 
and then analyzed using a Q-TOF Ultima tandem mass 
spectrometer (Micromass/Waters) with electrospray ion-
ization. The instrument was calibrated using the fragment 
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ion masses of doubly protonated Glu-fibrinopeptide. The 
MS/MS data were processed using Masslynx software 
(Micromass) to produce peak lists for database searching. 
MASCOT (Matrix Science) was used as the search engine. 
Data were searched against the NY-2A non-redundant 
database (Fitzgerald et al., manuscript in preparation).
Results
Cloning and identification of cviQIIM
Clones of cviQIIM were obtained by challenging a ge-
nomic library of NY-2A with MnlI [CCTC(7/6); GmAGG 
sequences are not cleaved by MnlI]. M.CviQII was pre-
dicted to modify the adenine in RAG sequences. E. 
coli cells containing plasmid DNA that express MTase 
M.CviQII should be resistant to MnlI cleavage. Sequenc-
ing the plasmids from two MnlI partially resistant clones 
led to the identification of a 269 codon ORF (Figure 1, 
predicted molecular weight of 31 kDa) whose deduced 
amino acid sequence indicates it is a m6A MTase [13]. 
In addition to motifs PXXGXG (motif I) and NPPF (mo-
tif IV) that are characteristic of m6A MTases (Figure 2), 
M.CviQII also contains motifs II, III, V, VI, VIII, and X 
that are shared by cytosine and adenine MTases. Further-
more, the linear order of the motifs, i.e. motif X followed 
by I to VIII indicates that M.CviQII is a member of the γ-
subtype of m6A MTases (m6A γ MTase) [13].
Members of m6A γ MTases typically have relatively 
low sequence identity to each other [13, 14]. For exam-
ple, M.TaqI, M.HincII, M.EcoKI, M.SbfI, M.VspI, M.XmnI, 
and M.PstI only share about 10% amino acid identity. Se-
quence identity is also low among some of the chlorella vi-
rus m6A γ MTases. M.CviBIII (from chlorella virus NC-1A) 
and M.CviRI (from chlorella virus XZ-6E) only have 14% 
and 11% amino acid sequence identity, respectively, with 
M.CviQII. However, there is 35% amino acid sequence 
identity between M.CviBIII and M.CviRI. Among all 
known chlorella virus m6A MTases, M.CviQI (recognition 
sequence GTAC), also from virus NY-2A [2], is most simi-
lar to M.CviQII with 24% amino acid sequence identity.
A BLAST search of GenBank (as of October 2005) 
identified two putative m6A γ MTases from evolution-
arily distant bacteria that resemble M.CviQII (Figure 2); 
an unidentified ORF from Sphingopyxis alaskensis RB2256 
(ZP_00579458) and a putative Type II MTase from Heli-
cobacter pylori J99 (NP_223729) have 34% and 23% amino 
acid sequence identity with M.CviXII, respectively. Like 
M.CviQII, these two putative bacterial m6A γ MTases 
lack motifs VII and IX, but contain all the other DNA 
MTase motifs.
Alignment of M.CviQII and M.CviQI amino acid se-
quences with the two putative bacterial m6A γ MTases 
revealed a conserved region between motifs VI and VIII 
(Figure 2). This region, termed motif VII*, contains con-
sensus AF residues that are flanked by charged and hy-
drophobic residues, respectively. Motif VII* could serve 
the same function as motif VII which is involved in form-
ing the catalytic region [15].
Identification of cviQIINt
Like bacteria, chlorella virus REase-encoding genes 
are always located near their cognate DNA MTase gene, 
although the spacing and relative orientation of the two 
Figure 1. Gene organization of the CviQII N-M system. The MTase gene (cviQIIM) precedes the NEase gene (cviQIINt) in the same 
orientation. The M.CviQII ORF spans nucleotides 495–1304 and encodes a protein of 269 amino acids, whereas the Nt.CviQII ORF 
spans nucleotides 1301–2953 and encodes a protein of 550 amino acids. The first four nucleotides of cviQIINt (ATGA) overlap the 
last four nucleotides of cviQIIM such that the cviQIINt translational start codon overlaps the cviQIIM stop codon. The C-terminal 
deletion variants N528, N509, and N413 are diagrammed below the wt Nt.CviQII.
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genes can vary [14]. Therefore, we sequenced the NY-2A 
genomic DNA adjacent to cviQIIM and identified an ORF 
of 550 codons (Figure 1, in the same orientation as the 
cviQIIM gene but in a different reading frame) that over-
laps cviQIIM by four nucleotides. As a result, the stop co-
don of M.CviQII (ATGA) overlaps the Nt.CviQII start co-
don (ATGA). The Nt.CviQII ORF (predicted molecular 
weight 63 kDa) has low sequence identity to all known 
site-specific endonucleases except two from chlorella vi-
ruses. Nt.CviQII has 34% and 23% amino acid sequence 
identity with Nt.CviPII and CviJI [CviJI short form, with-
out the EEKKR repeats at the N-terminus, [16]], respec-
tively (Figure 3). Nt.CviPII is a three-base NEase (↓CCD) 
from chlorella virus NYs-1 [6], whereas, CviJI, from chlo-
rella virus IL-3A, produces dsDNA breaks (RG ↓ CY) with 
blunt ends [16] and [17]. There is one Type II endonucle-
ase catalytic motif in Nt.CviQII, P237D238-X[25]–D264GK266 
(Figure 3) [18]. This catalytic motif can be aligned to one 
of the putative catalytic motifs of Nt.CviPII (A234E235-X[22]- 
D258GK260) [6].
Nt.CviQII is at least 150 amino acids larger than all 
other known chlorella virus site-specific endonucleases. 
This increased length is due primarily to many tandem 
repeats located between amino acids 414 and 485: 14 re-
peats of VKTP, 3 repeats of VKSP, 1 VLTP, and 1 VKIL 
(Figure 3). Cell-free transcription/translation of a trun-
cated mutant of Nt.CviQII indicates that the tandem re-
peat sequences are not required for DNA nicking activity 
(see below). The biological role of the short amino acid re-
peats, if any, remained to be studied.
Figure 2. Alignment of M.CviQII amino acid sequence to its closest matches from GenBank. ZP_00579458 and NP_223729 are pu-
tative ORFs from Sphingopyxis alaskensis RB2256 and Helicobacter pylori J99, respectively. M.CviQI is a γ-subtype of m6A MTase 
isolated from chlorella virus NY-2A with a recognition sequence of GTmAC. DNA MTase motifs are underlined. Motif VII is ab-
sent in all four proteins; however, all four proteins have a similar amino acid sequence, labeled motif VII*. Identical residues are 
shown in black boxes and conserved residues in MTase motifs are indicated by an asterisk.
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M.CviQII MTase activity
The genomic library of NY-2A was generated by ligat-
ing Sau3AI (↓ GATC) fragments of NY-2A genomic DNA 
to BamHI (G↓ GATCC) cleaved pUCAC. Because there is 
a Sau3AI site within the ORF of cviQIIM near the 5′ end, 
the resulting pUCAC-cviQIIM clone generated a modified 
form of M.CviQII such that the N-terminal 12 amino acid 
residues of M.CviQII were replaced by the N-terminal 16 
amino acid residues of LacZ α fragment. To determine if 
bacterial DNA was methylated by this modified M.CviQII 
in the transformed cells, total DNA (genomic and plasmid 
pUCAC-cviQXIM DNAs) was isolated from the trans-
formed cells and incubated with REases containing recog-
nition sequences overlapping NAG: HindIII (A ↓ AGCTT) 
and AflII (C ↓ TTAAG) for AAG; MnlI (↓N6GAGG) and 
PleI (GAGTCN4↓) for GAG; PvuII (CAG ↓ CTG) for CAG 
and XbaI (T ↓ CTAGA) for TAG; ScaI (AGT ↓ ACT) and 
EcoNI (CCTNN ↓ NNNAGG) for NAG. Two REases, 
DraI (CACNN ↓ GTG) and XmnI (GAANN ↓ NNTTC), 
with unrelated recognition sequences were also tested 
on the E. coli DNA as controls (Figure 4A). The DNA was 
largely resistant to HindIII, AflII, MnlI, PleI, PvuII, XbaI, 
ScaI, and EcoNI cleavage but not to DraI and XmnI. There-
Figure 3. Alignment of Nt.CviQII amino acid sequences with its closest matches in GenBank. Nt.CviPII (↓CCD) and CviJI 
(RG ↓ CY) are from chlorella viruses NYs-1 and IL-3A, respectively. The putative active site residues in Nt.CviQII indicated by an 
asterisk. The asterisks also indicates the putative active site residues of Nt.CviPII, which can be aligned to that of Nt.CviQII. Tan-
dem repeats of VKTP are indicated. The terminal residues of truncation mutants NQN413, NQN509, and NQN528 are indicated 
by arrows.
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fore, M.CviQII modifies the adenine in AAG, GAG, CAG, 
and TAG sequences, which means it methylates AG se-
quences. The presence of a small amount of linearized 
plasmid DNA in the HindIII, MnlI, PleI, and PvuII reac-
tions indicates that M.CviQII does not modify every AG 
site in E. coli.
Full-length M.CviQII was also cloned and expressed 
as a recombinant fusion protein. The cviQIIM gene was 
ligated to pTXB1 to produce a C-terminal fusion protein 
containing the Mxe GyrA intein and chitin-binding do-
main (CBD). However, the expressed fusion protein was 
insoluble. After denaturing and refolding, the fusion pro-
tein was cleaved by the intein-mediated reaction and the 
protein was purified by ion exchange chromatography 
to 60% purity (Figure 4B). This partially purified pro-
tein was assayed for MTase activity using pUC19 DNA as 
a substrate. After incubating pUC19 DNA with the par-
tially purified M.CviQII and AdoMet, the DNA product 
was incubated with appropriate REases to determine if 
specific sites were protected (Figure 4C). Similar to the re-
sults of the in vivo experiments, M.CviQII partially pro-
tected AAG (against HindIII), GAG (against MnlI and 
PleI), CAG (against PstI) and TAG (against XbaI) sites 
from cleavage. These same REases cleaved control pUC19 
into the expected fragments. MspI (C ↓ CGG) and PvuI 
(CGAT ↓ CG), which are not inhibited by m6A, cleaved 
the M.CviQII-modified pUC19 to completion. However, 
like the in vivo methylation experiments, M.CviQII pro-
tection was not complete and both nicked and linearized 
plasmid DNAs were observed in all of the reactions.
Figure 4. (A) In vivo protection of E. coli DNA by M.CviQII. Total DNA isolated from pUCAC-cviQII-transformed ER1992 was 
challenged with REases with NAG recognition sequences (upper panel). The E. coli DNA, nicked, linearized, and supercoiled 
forms of pUCAC-cviQIIM are indicated. The lower panel shows that the REases cleaved unmodified pUC19, pBR322, or φX174 ds-
DNA. (B) Purification of M.CviQII. The insoluble M.CviQII-intein-CBD fusion protein was refolded and intein-mediated cleavage 
was induced by DTT. The protein solution was then loaded onto a SP column and eluted using a linear gradient of NaCl. The ar-
rowhead indicates the band corresponds to M.CviQII on a 10–20% SDS–PAGE. (C) In vitro activity of M.CviQII. Substrate pUC19 
DNA was incubated with or without M.CviQII in the presence of AdoMet followed by incubation with the indicated REases. Par-
tial recognition sequences are shown on top of the corresponding REases. Substrate pUC19 DNA incubated with M.MspI, fol-
lowed by MspI digestion, served as a control.
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Cloning Nt.CviQII and construction of deletion mutants
The standard procedure for cloning R-M systems is 
to protect the host DNA by expressing the MTase gene 
before cloning the REase [19]. However, due to the high 
number of Nt.CviQII nicking sites in the host genome, 
cloning cviQIINt was expected to be difficult. We at-
tempted to protect the host DNA by over-expressing 
M.CviQII before introducing cviQIINt into E. coli. The 
cviQIIM gene containing an optimal ribosome binding 
site and spacing was ligated to pACYC184 or pLT7K [20] 
because these two plasmids are compatible with the plas-
mids used to express cviQIINt. However, plasmid DNA 
isolated from E. coli ER2566 transformed with these two 
cviQIIM containing plasmids was only partially protected 
against MnlI cleavage (data not shown).
Full-length cviQIINt was amplified from NY-2A ge-
nomic DNA by PCR and ligated into several plasmids in-
cluding: (i) pR976 (vector constructed by P. Riggs, NEB), 
a low copy plasmid with a Ptac promoter used to success-
fully clone Nt.CviPII [6] in the presence of pUCAC-cviQ-
IIM, (ii) pLT7K in the presence of pACYC184-cviQIIM, 
and (iii) a single-copy plasmid with inducible copy num-
ber that was derived from pBAC with a Ptac promoter 
(pBACtac, unpublished results, J.C. Samuelson, NEB). All 
attempts to clone cviQIINt into cviQIIM containing cells 
were unsuccessful, either no inserts were obtained or the 
inserts had altered cviQIINt sequences.
We then tried to express C-terminal truncation mu-
tants of Nt.CviQII in E. coli and reconstruct the full-length 
protein by ligating C-terminal peptide sequences to the 
recombinant proteins using an intein-mediated peptide 
ligation system (NEB). Two Nt.CviQII truncation mu-
tants were constructed. The C-terminal 41 and 22 amino 
acid residues were deleted in NQN509 (509 amino acids) 
and NQN528 (528 amino acids), respectively (Figure 3). 
Ser509 of NQN509 and Ser528 of NQN528 were mutated 
to Cys to facilitate intein-mediated peptide ligation. The 
two proteins were expressed as C-terminal fusions to in-
tein Mxe GyrA followed by a CBD, which increased the 
size of the recombinant truncated proteins by ~26 kDa. 
The resulting constructs pTXB1-NQN509 and pTXB1-
NQN528 were expressed in E. coli ER2566. The expression 
levels were relatively high and independent of the pres-
ence of the cviQIIM gene in the host cells. Proteins that 
eluted from the chitin column were ligated to peptides 
with an N-terminal Cys in the presence of reducing agent 
(50 mM MESNA) at 4 °C and 25 °C. About 50% of the 
truncated proteins were ligated to the peptides (Figure 
5A). The ligated proteins were further purified by hepa-
rin column chromatography and assayed for DNA nick-
ing activity.
Figure 5. (A) Intein-mediated peptide ligation. Truncated Nt.CviQII mutants NQN509 and NQN528 were ligated to peptides C42 
and C23, respectively, by intein-mediated peptide ligation at 4 °C or 25 °C for 22 h. Ligated and unligated proteins are indicated. 
(B) DNA nicking activity of the truncation mutants and ligated proteins incubated for various times at 30 °C. One microgram of 
pUC19 DNA was incubated with 0.3 μg of the proteins and analyzed on a 1.5% agarose gel.
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DNA nicking activity of Nt.CviQII and its truncation mutants
DNA nicking activity of the Nt.CviQII truncated mu-
tants and reconstructed wild-type proteins were assayed 
using the 2686 bp closed circular pUC19 DNA as a sub-
strate; the two DNA strands of the plasmid contain 180 
RAG sites. Complete cleavage of the plasmid should re-
sult in ssDNA fragments of ~50 nucleotides. One micro-
gram (0.56 pmol) of pUC19 DNA was incubated with 4 μg 
(60 pmol) of protein at 30 °C. All of the proteins exhibited 
DNA nicking activity; however, none of them cleaved 
pUC19 to 50 nucleotides in 1 h (Figure 5B). Therefore, 
longer incubations were used. The ligated NQN509 + C42 
protein had the highest DNA nicking activity in the first 
2 h and its cleavage products became smaller with time 
(Figure 5B). Both ligated and unligated NQN528 proteins 
have similar activity. After incubating for 22 h, the cleav-
age products were 100–200 bp, indicating that the re-
action did not go to completion. Incubating the cleavage 
products with fresh NQN509 cleaved the DNA fragments 
into smaller pieces, indicating that Nt.CviQII was inacti-
vated during extended incubation before the cleavage re-
actions were completed (data not shown).
Since a stable cleavage pattern was not obtained in 
2 h, one enzyme unit of Nt.CviQII and its deletion mu-
tants was defined as the amount of protein needed to give 
50% cleavage of 1 μg of closed-circular pUC19 DNAs to 
a nicked circular form in 1 h. Using this definition, the 
specific activities of NQN509 and NQN509 + C42 were 
107,000 U/mg and 213,000 U/mg, respectively. The spe-
cific activities of NQN528 and NQN528 + C23 were both 
80,000 U/mg (results not shown). The lower specific ac-
tivities of NQN528 and its ligated protein may be due to 
either altering protein conformation or the Ser528 to Cys 
substitution.
Protein NQN509 was chosen for further study because 
of its relatively high specific activity and it was easier to 
produce. The chitin column fractions of NQN509 were 
pooled and further purified through heparin and hy-
droxyapatite chromatography. A total of 15.6 mg of pu-
rified protein with 3 × 106 U were obtained (Table 1). The 
purification is only 1.4-fold compared to the chitin col-
umn chromatograph because relatively high purity can 
be obtained by the combination of chitin column and in-
tein-mediated cleavage (Figure 6A). One hundred units of 
purified NQN509 were incubated with 1 μg of pUC19 at 
Figure 6. Purification and DNA nicking activity of truncation mutant NQN509. (A) The lysate supernatant from 2 L of expression 
culture (In) was loaded onto a chitin column. After intein-mediated cleavage, the mutant protein was eluted (Ch). The eluted pro-
tein was diluted, and loaded onto a heparin column. The eluted protein was pooled (Hp) and dialyzed against potassium phos-
phate buffer. The dialyzed protein solution was loaded onto a hydroxyapatite column and the eluted protein was concentrated 
and stored (Hy). The arrowhead indicates the band that corresponds to NQN509 on a 4–20% SDS–PAGE. (B) One hundred units 
of the purified NQN509 were incubated with 1 μg of pUC19 at the indicated temperatures for 1 h. pUC19 linearized by NdeI or 
without enzyme treatment served as controls for linearized and supercoiled DNA, respectively.
Table 1. Purification of NQN509
                                               Total                         Total                                     Specific                          Purification 
Steps                                  proteina (mg)           activitya (U)b                   activity (U/mg)                      Yield (%)                             (fold)
Lysate supernatant 350 — — — —
Chitin column 29 4.0 × 106 138 × 103 100 1.0
Heparin 20 3.2 × 106 160 × 103   80 1.2
Hydroxyapatite 15.6 3.0 × 106 192 × 103   75 1.4
a The numbers are per Liter culture.
b One enzyme unit is defined as the amount of enzyme needed to convert half of 1 μg of closed-circular form of pUC19 to nicked circular form.
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temperatures from 4 to 65 °C for 1 h (Figure 6B). The en-
zyme exhibited optimal activity at 16–25 °C with reduced 
activity above 45 °C.
To compare the activity of the truncation mutants to 
wt Nt.CviQII, a small quantity of wt enzyme was pro-
duced in a cell-free transcription/translation system, be-
cause we were unable to clone and express wt Nt.CviQII 
in E. coli. Three Nt.CviQII truncation mutants were pro-
duced by the same system in parallel: NQN528, NQN509, 
and NQN413 (with the last 137 codons deleted). The syn-
thesized proteins contained a His-tag and their presence 
in the resulting transcription/translation reaction was 
confirmed by immuno-blotting using an anti-His-tag anti-
body (data not shown). NQN528 and NQN509 have simi-
lar reaction rates as wt Nt.CviQII over 4 h (Figure 7). Un-
expectedly, NQN413 has a slightly higher initial rate than 
the wt enzyme. Because NQN413 lacks the entire C-ter-
minal tandem repeat sequences, we conclude that the 
Nt.CviQII C-terminal 137 amino acids are not required 
for DNA nicking activity.
Nt.CviQII nicking sites
To determine the Nt.CviQII cleavage sites, plas-
mid pBR322 was cleaved with dilutions of NQN509 and 
NQN509 + C42 at 30 °C for 1 h. The cleaved fragments 
were filled-in using the Klenow fragment and cloned into 
pUC19. Sequencing the junctions of 10 cloned pBR322 
fragments indicated that the two enzymes cleaved the 
plasmid 5′ to the middle adenine at AAG or GAG sites 
(data not shown). The length of the cleavage products 
ranged from 60 to 300 bp with an average of 165 and 
172 bp for NQN509 and NQN509 + C42, respectively 
(data not shown). The 5′ end always started with AG and 
the 3′ end always ended with CT (the reverse complement 
of AG) in all the cloned fragments. These results indicate 
that both NQN509 and NQN509 + C42 only cleaved plas-
mid DNA in one of the strands rather than both because 
there would be a junction of TY … RA for staggered end 
cleavage or Y … R for blunt end cleavage. Moreover, only 
the RAG containing strand (not YTC) was cleaved. Oth-
Figure 7. (A) DNA nicking activity of wt and truncation mutants of Nt.CviQII produced by cell-free transcription/translation. 
ORFs of full-length wt, truncation mutants NQN528 (N528), NQN509 (N509), and NQN413 (N413) were amplified from NY-2A 
genomic DNA in PCR. T7 promoter and a ribosome-binding sequence were added 5′ to the ORFs by appropriate primers. A PstI 
ORF served as a positive control for the in vitro transcription/translation system. Cell-free transcription/translation products 
were incubated with pUC19 DNA at 30 °C for 2 h. pUC19 DNA was cleaved by PstI and Nt.SapI to produce linearized and nicked 
DNA, respectively. (B) Comparison of reaction rates of wt Nt.CviQII, NQN528, NQN509, and NQN413. The DNA nicking activ-
ity assay was continued for 4 h and the intensities of nicked and supercoiled DNA from two independent experiments were aver-
aged. Fractions of nicked DNA were plotted against time and curve fitting was done using KaleidaGraph.
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erwise, some fragments would end as TY … RA. The re-
sults agree with experiments reported previously where 2 
RAG sites were sequenced [2].
Nt.CviQII is packaged in NY-2A virions
Attempts to identify all of the virus-encoded proteins 
that are packaged in the NY-2A virion (Dunigan et al., 
manuscript in preparation) indicated that Nt.CviQII is 
packaged in the virion, whereas its corresponding MTase 
M.CviQII is not. The identified peptide fragments cover 
32% of the Nt.CviQII protein with Mowse scores of high 
confidence. One concern was that the enzyme might be a 
contaminate protein on the surface of the virions. How-
ever, virions-treated with protease K during their purifica-
tion did not remove Nt.CviQII. [Note: Most proteases have 
little or no effect on PBCV-1 infectivity (Van Etten, unpub-
lished results)]. These results suggest that Nt.CviQII has a 
physiological function during an early phase of virus infec-
tion. Separate studies indicate that NY-2A infection causes 
rapid degradation of host chlorella chromosomal DNA 
(Agarkova et al., submitted for publication). Nt.CviQII 
could be involved in this degradation process which may 
aid in either shutting off host transcription during infec-
tion, allow for a recycling of nucleotides into virus prog-
eny DNA, and/or prevent subsequent secondary virus in-
fections by destroying the competing viral DNA.
Discussion
One unusual property of chlorella viruses is that they 
encode multiple Type II DNA R-M systems [1, 21]. Vi-
rus NY-2A has the most heavily methylated DNA among 
chlorella viruses (45% of the cytosines are m5C and 37% 
of the adenines are m6A) and consequently its DNA is re-
sistant to most REases [3]. In the current manuscript we 
demonstrated that M.CviQII methylates AG sequences in 
vitro and in vivo in a heterologous host (E. coli). Because 
M.CviQII modifies a dinucleotide sequence, it can ac-
count for ~25% of the adenine methylation in NY-2A. To 
our knowledge M.CviQII is the first m6A MTase to recog-
nize a dinucleotide sequence. This property of M.CviQII 
can be used to study the sensitivity of restriction endonu-
cleases with overlapping AG sites.
After most of the experiments described in this man-
uscript were completed, the 370 kb NY-2A genome se-
quence became available (http://greengene.uml.edu). 
Amazingly, NY-2A contains 18 putative MTase-encoding 
genes (Table 1) (Fitzgerald et al., manuscript in prepara-
tion). In addition to the CviQII N-M system described in 
this report, NY-2A encodes another R-M system, named 
CviQI. CviQI is a typical Type II REase that cleaves 5′ 
of the T in G ↓ TAC sequences [2, 4]. Its cognate MTase 
M.CviQI is also a m6A γ MTase that modifies adenine 
in its recognition sequence. The cviQIR gene was cloned 
and expressed in E. coli before the viral genome was se-
quenced (Zhu and Xu, unpublished results).
Previously the methylation sites of eight other NY-
2A MTases were identified by either cloning the gene 
(M.CviQIII, M.CviQV, M.CviQVI, and M.CviQVII) or de-
ducing the site from the resistance of NY-2A DNA to se-
lected REases (M.CviQIV, M.CviQVIII, M.CviQIX, and 
M.CviQX) [2]. In fact, the M.CviQII methylation site was 
inferred originally from the sensitivity/resistance of NY-
2A DNA to selected REases; the predicted site (RAR) was 
nearly correct. Now knowing that NY-2A has 18 MTases-
encoding genes, it is likely that the methylation site at-
tributed to M.CviQII previously results from two or more 
MTases with overlapping sequence specificities [2].
In addition to the CviQI R-M and CviQII N-M systems, 
the 16 remaining MTases, which are located throughout 
the NY-2A genome, may be orphan MTases because no 
ORFs near these MTase-encoding genes resemble known 
REases or NEases (Table 2) . The NY-2A gene number as-
signed to the 18 MTases, as well as their closest homo-
logs from other chlorella viruses, are listed in Table 1. 
Eleven of the 18 MTases are predicted to be m6A MTases 
and seven are predicted to be m5C MTases. Of the 11 
m6A MTases, seven are m6A γ MTases, three are m6A α 
MTases, and one is a m6A β MTase. M.CviQXV resem-
bles M.Hpy188I more than chlorella MTases.
Twelve of the 18 NY-2A MTases have >45% amino acid 
identity with MTases from other chlorella viruses (Ta-
ble 1). In particular, M.CviQVIII and M.CviQIV have 99% 
and 89% amino acid identity to M.CviPI and M.CviPII, 
respectively, from chlorella virus NYs-1 [2, 22]. The high 
sequence identity among MTases from different viruses 
suggests that the MTase genes have been shuffled among 
the viruses during the course of evolution. Gene duplica-
tion within a virus, however, is not very common because 
none of the NY-2A MTases have more than 50% amino 
acid identity with each other.
Including the two site-specific endonucleases, at least 
20 of NY-2A’s putative 400 protein-encoding genes (5% 
of the genes) produce proteins involved in R/N-M func-
tions; presumably they must serve some physiological 
function(s). The Nt.CviQII enzyme is packaged in the vi-
rion and may be involved in degrading host chromo-
somal DNA, which occurs almost immediately after NY-
2A infection (Agarkova et al., submitted for publication). 
However, other related viruses that infect the same chlo-
rella host survive with fewer R-M encoding genes. For 
example, the prototype chlorella virus, PBCV-1 has five 
MTase-encoding genes, two of which have companion 
REases (CviAI and CviAII) [1].
NY-2A not only encodes many putative genes involved 
in R-M functions, it also has 28 putative homing endo-
nuclease-encoding genes and six putative transposase-
encoding genes (Fitzgerald et al., manuscript in prepa-
ration). Currently, it is not known if any of these genes 
encode functional enzymes. Assuming that at least some 
of these genes encode functional proteins, one might ex-
pect the NY-2A genome to be unstable. However, we have 
grown NY-2A for about 20 years in the laboratory and 
have not observed any evidence of genome instability.
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Recombinant M.CviQII does not methylate every AG 
sequence in substrate DNA in vitro because all eight 
REases that are inhibited by m6A in AG sequences can 
partially cleave M.CviQII-treated DNA. This lack of com-
plete protection is unlikely to be due to sub-optimal reac-
tion conditions (such as buffer composition or concentra-
tion of AdoMet) because permutations of various reaction 
conditions did not improve the protection (results not 
shown). Likewise, both plasmid and chromosomal DNAs 
isolated from E. coli transformed with the cviQIIM gene 
on high copy plasmids and controlled by a constitutive 
lac promoter (pUCAC-cviQIIM) were only partially re-
sistant to these same eight REases. However, NY-2A ge-
nomic DNA is completely resistant to Nt.CviQII. There-
fore, either M.CviQII methylates all of the AG sites of the 
virus DNA during virus replication in its natural hosts 
(chlorella cells), or other NY-2A MTases methylate over-
lapping AG sites. For example, the recognition sequence 
of M.CviQVI has been deduced to be GANTC [2].
Nt.CviQII is 150–200 amino acids larger than all the 
other chlorella virus site-specific nucleases described to 
date. This increased size is due primarily to a tetrapeptide 
tandem repeat VKTP sequence located near the C-termi-
nus (amino acids 414–485). A BLAST search of the repeat 
sequence against proteins in GenBank revealed some sim-
ilar, but not identical, tandem repeats in uncharacterized 
ORFs from the fungus Gibberella zeae pH 1, the cellular 
slime mold Dictyostelium discoideum, a putative ATP-de-
pendent Acyl-CoA synthetase from protozoan Plasmodium 
falciparum 3D7 and a hypothetical protein from chimpan-
zee Pan troglodytes.
The function of the Nt.CviQII tandem repeat is un-
known. In vitro transcription/translation experiments es-
tablished that it is not required for NEase activity because 
Nt.CviQII truncation mutants have similar NEase activ-
ity as the full-length protein. However, after writing this 
manuscript, a clone of full-length Nt.CviQII fused to the 
intein and CBD was obtained after a few more attempts 
of cloning. To our surprise, DNA nicking activity was 
detected in the membrane fraction of the induced cells. 
DNA nicking activity also occurred in the membrane frac-
tion of the truncated mutants NQN509 and NQN528, al-
beit to a lesser extent. Finding the recombinant full-length 
Nt.CviQII in the membrane fraction suggests that the C-
terminal sequence (the tetrapeptide repeats and the pro-
ceeding sequence) may contribute to the membrane lo-
calization of the protein. Since mutants NQN509 and 
NQN528 also have all of the tetrapeptide repeats, the C-
terminal sequence may target the protein to the mem-
brane. The tetrapeptide repeats could function to insert 
the protein into the membrane. Additional mutagenesis 
experiments will be conducted to explore this possibility.
Nt.CviQII is part of a short list of natural DNA nick-
ing enzymes. It joins Nt.CviPII from chlorella virus NYs-1 
in recognizing and nicking at very short recognition sites. 
It is interesting that Nt.CviQII has 34% amino acid iden-
tity with Nt.CviPII even though they are sensitive to dif-
ferent methylated nucleotides, i.e. Nt.CviQII is blocked 
by m6A and Nt.CviPII by m5C. Most REases and NEases 
from chlorella viruses recognize and cleave short (3–5 bp) 
recognition sequences (REBASE). Naturally occurring 
nicking endonucleases from other organisms, such as 
Table 2. DNA methyltransferases from virus NY-2A
Name NY-2A ORFd Recognition sequence Chlorella virus homologs aa identity (%) Type
M.CviQIa B543L GTmACa — — m6Aγ
M.CviQIIa B359R mAGa — — m6Aγ
M.CviQIIIa B16L TCGmAa M.CviBIII 75 m6Aγ
M.CviQIVb B774R GmATCb M.CviAI 81 m6Aα
M.CviQVa B230L TGCmAa M.CviRI 79 m6Aγ
M.CviQVIa B399R GmANTCa M.CviBI 82 m6Aα
M.CviQVIIa B236L CmATGa M.CviAII 80 m6Aα
M.CviQVIIIb B769R GmCb M.CviPI 99 m5C
M.CviQIXb B681L mCCDb M.CviPII 89 m5C
M.CviQXc B8R mCGRb — — m5C
M.CviQXIc B10R — — — m6Aβ
M.CviQXIIc B88L — M.CviAIII 49 m5C
M.CviQXIIIc B411L GmCc M.CviPI 45 m5C
M.CviQXIVc B416R TGCmAc M.CviSI 65 m6Aγ
M.CviQXVc B418R TCNGmAe — — m6Aγe
M.CviQXVIc B566R — — — m5C
M.CviQXVIIc B567L TGCmAc M.CviSI 85 m6Aγ
M.CviQXVIIIc B697R — M.CviAIV 85 m5C
a Proteins cloned and shown to have the indicated activity.
b Recognition sequences deduced from the sensitivity/resistance of NY-2A DNA to selected REases.
c MTases are putative.
d The DNA sequences of the ORFs are available at http://greengene.uml.edu/.
e The recognition sequence and subtype of M.CviQXV are deduced from its homologous MTase M.Hpy188I, which shows 41% se-
quence identity with M.CviQXV.
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Nt.BstNBI (GAGTCN4↓) [23], Nb.BsrDI(↓CATTGC) and 
Nb.BtsI (↓CACTGC) from Bascillus sp. recognize and nick 
5–6 bp recognition sequences (Xu and Zhu, unpublished 
results). Other nicking endonucleases such as Nt.SapI 
(GCTCTTCN↓) and Nt.AlwI (GGATCN4↓) have been cre-
ated by genetically engineering known REases [24, 25].
The G + C content of the cviQIIM gene is 40%, that is 
the same as the NY-2A genome. However, the G + C con-
tent of the cviQIINt gene is 36% and if the tandem repeats 
are removed the G + C content is 33%. A similar phe-
nomenon was observed with the CviPII N-M system in 
which cviPIINt is 32% G + C and cviPIIM is 43% G + C. In 
general, the G + C content of most chlorella virus genes 
is about 40%. The relatively low GC contents of the two 
NEase genes suggest that they might have been acquired 
separately from their companion MTase genes.
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